Curated News
By: NewsRamp Editorial Staff
June 16, 2026
Dr. Art Rastinehad Named Castle Connolly Top Doctor for 12th Year
TLDR
- Dr. Rastinehad's Top Doctor designation for 12 years signals unmatched expertise in precision prostate care, giving patients a competitive edge in treatment.
- He pioneered MR/US fusion biopsy and focal therapy, using image-guided techniques to match each patient's diagnosis to the right treatment.
- By coordinating personalized evaluations and treatments, Dr. Rastinehad empowers men to make informed decisions, improving quality of life.
- He was the first dual fellowship-trained urologic oncologist and interventional radiologist, blending cancer surgery with minimally invasive therapy.
Impact - Why it Matters
This news matters because it highlights a physician at the forefront of precision prostate care, offering men with prostate cancer or BPH access to cutting-edge, individualized treatments. Dr. Rastinehad's expertise in MRI-targeted biopsy and focal therapy means patients can receive less invasive, more accurate diagnoses and treatments, potentially improving outcomes and quality of life. For the millions of men facing prostate health decisions, this recognition assures that top-tier, patient-centered care is available, emphasizing the importance of personalized medicine over one-size-fits-all approaches.
Summary
Dr. Art Rastinehad, a renowned urologist and interventional radiologist, has been named a 2026 Castle Connolly Top Doctor for the 12th time, a honor given to only 7% of U.S. physicians. Recognized for his expertise in precision prostate care, Dr. Rastinehad serves as professor of urology and radiology, vice chair of urology at Northwell's Lenox Hill Hospital, and Northwell Health System director for prostate cancer. His clinical focus includes MRI-targeted biopsy, focal therapy, and prostate artery embolization for enlarged prostate/BPH. He emphasizes a tailored approach: 'Every patient deserves a careful review of his PSA history, MRI findings, biopsy results, prostate size, urinary symptoms, cancer risk, and personal goals before choosing a treatment path.'
Dr. Rastinehad's groundbreaking research includes early validation of MR/US fusion biopsy for prostate cancer detection in the U.S., and he was the first dual fellowship-trained urologic oncologist and interventional radiologist, combining cancer surgery, advanced imaging, and minimally invasive therapies. Key achievements include publishing the first series on prostate artery embolization in 2006, serving as principal investigator for UroNav/Philips MR/US fusion technology, and co-founding the Focal Therapy Society. His practice at the urology department at Lenox Hill Hospital offers advanced care for men with elevated PSA, abnormal MRI, localized prostate cancer, and BPH.
Top Doctors are peer-nominated and selected by Castle Connolly's physician-led research team, based on criteria including medical education, training, and disciplinary history. Dr. Rastinehad's recognition underscores his commitment to precision prostate care, helping men make informed decisions through coordinated evaluation and individualized treatment options. His unique background and over 20 years of experience continue to advance image-guided prostate care, making him a leading figure in the field.
Source Statement
This curated news summary relied on content disributed by 24-7 Press Release. Read the original source here, Dr. Art Rastinehad Named Castle Connolly Top Doctor for 12th Year
